Project Details
| Short title | New anti-FXIIa using microfluidic assays |
|---|---|
| Status | Finished |
| Effective start/end date | 1/10/20 → 30/09/22 |
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
-
Capillary electrophoresis as a fragment screening tool to cross-validate hits from chromogenic assay: Application to FXIIa
Davoine, C., Fillet, M. & Pochet, L., 1 May 2021, In: Talanta. 226, p. 122163 122163.Research output: Contribution to journal › Article › peer-review
-
Factor XII/XIIa inhibitors: Their discovery, development, and potential indications
DAVOINE, C., BOUCKAERT, C., Fillet, M. & POCHET, L., 1 Dec 2020, In: European Journal of Medicinal Chemistry. 208, 112753.Research output: Contribution to journal › Review article › peer-review
Open AccessFile121 Downloads (Pure)
-
Affinity Capillary Electrophoresis in Fragment-Based Drug Discovery Projects, a Tool for Hit Discovery and Binding Site Characterization
DAVOINE, C. (Speaker)
4 Jul 2022Activity: Talk or presentation types › Oral presentation
-
6th EFMC-YSN MedChemBioOnline: PROTAC and Small Molecules Development
DAVOINE, C. (Participant)
28 Jan 2021Activity: Participating in or organising an event types › Participation in conference
-
NovAliX Virtual Conference 2020
DAVOINE, C. (Participant)
28 Oct 2020Activity: Participating in or organising an event types › Participation in conference